Deep Experience overcoming business and socio-cultural differences globally
Extensive ‘C’ level network nurtured for over 23+ years
Global Deal making experience of 250+ years combined
Market Intelligence and IP Research using new age tools
Augmenting your team to save time, effort & cost
130+ Clients served and 235+ Assignments delivered
Clients
Projects
Countries
Years Global Experience
Your Needs We Serve
Support in M&A and Divestment of Assets, Techs, IP, Companies etc.
Advisory and BD support for Funding and Venture Capital needs
Various types of development partnering support
Support all stages of licensing (Product/IP/Tech) from Pre-Clinical to on the Market
Equity Investment. AU $17M initial deal done. Total deal value of AU $50M+ on Acquisition.
Numerous Investments incl. Corporate Venture. Secured partnership with a VA hospital.
Successfully facilitated evaluation and deal finalizing process for Denosumab Biosimilar for Japan.
Dermal Delivery Platform. 4 Deals signed with 3 companies for 18+ geographies.
Novel Protein Therapeutic Platform. 2 Deals Done with Zydus Cadila and Stelis Biopharma.
Finding customers for Peptides API. Partnered with 8 Companies globally.
We are eager to contribute to your Success, please let us know your needs for a preliminary evaluation at no cost.
CHICAGO, IL - September 01, 2026 - Aagami, Inc. is pleased to announce a strategic new client win: we have been appointed by a venture-backed bio...
Read MoreCHICAGO, IL — August 01, 2026 — Aagami, Inc., a premier life sciences management consulting firm based in the Chicago area, announced today t...
Read MoreCHICAGO, IL - July 07, 2026: Aagami is pleased to announce a new client win: we have been appointed by an innovative biopharmaceutical company ba...
Read MoreSend us a request on action@aagami.com
